Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Solomon

Showing results (91-100 of 184) with videos related to

Pageof 19
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2016
BRAF Inhibition in BRAFV600E-Positive Anaplastic Thyroid CarcinomaAnnette M Lim, Graham R Taylor, Andrew Fellowes, et al.
Oral Oncology|November 22, 2025
Evaluating CD103<sup>+</sup> intratumoral immune cell abundance and PD-L1 CPS in primary tumors versus lymph nodes in Human papillomavirus associated oropharyngeal CancerChia Yuen Chong, Richard J Young, Annette M Lim, et al.
Internal Medicine Journal|May 26, 2017
Survival difference according to mutation status in a prospective cohort study of Australian patients with metastatic non-small-cell lung carcinomaLavinia Tan, Marliese Alexander, Ann Officer, et al.
Oral Oncology|September 5, 2020
Validation of local p16 testing for determination of human papilloma virus status eligibility on a low risk oropharyngeal cancer trial - A Trans-Tasman Radiation Oncology Group studyRichard J Young, Benjamin Solomon, June Corry, et al.
Molecular Cancer Research : MCR|October 20, 2011
Inhibition of DNA-dependent protein kinase induces accelerated senescence in irradiated human cancer cellsArun Azad, Susan Jackson, Carleen Cullinane, et al.
British Journal of Cancer|July 21, 2017
Lung cancer prognostic index: a risk score to predict overall survival after the diagnosis of non-small-cell lung cancerMarliese Alexander, Rory Wolfe, David Ball, et al.
Plos One|November 25, 2015
Spleen Volume Variation in Patients with Locally Advanced Non-Small Cell Lung Cancer Receiving Platinum-Based Chemo-RadiotherapyShu Wen Wen, Sarah J Everitt, Justin Bedő, et al.
ANZ Journal of Surgery|September 15, 2016
Impact of sex on prognostic host factors in surgical patients with lung cancerZoe Wainer, Gavin M Wright, Karla Gough, et al.
Asia-Pacific Journal of Clinical Oncology|March 1, 2014
Multicenter randomized, open-label phase II trial of sequential erlotinib and gemcitabine compared with gemcitabine monotherapy as first-line therapy in elderly or ECOG PS two patients with advanced NSCLCMichael Michael, Shane C White, Ehtesham Abdi, et al.
Medical Oncology (Northwood, London, England)|September 8, 2017
EGFR and KRAS mutations do not enrich for the activation of IL-6, JAK1 or phosphorylated STAT3 in resected lung adenocarcinomaTimothy D Clay, Prudence A Russell, Hongdo Do, et al.
Pageof 19

Showing results (91-100 of 184) with videos related to

Sort By:
Pageof 19
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2016
BRAF Inhibition in BRAFV600E-Positive Anaplastic Thyroid CarcinomaAnnette M Lim, Graham R Taylor, Andrew Fellowes, et al.
Oral Oncology|November 22, 2025
Evaluating CD103<sup>+</sup> intratumoral immune cell abundance and PD-L1 CPS in primary tumors versus lymph nodes in Human papillomavirus associated oropharyngeal CancerChia Yuen Chong, Richard J Young, Annette M Lim, et al.
Internal Medicine Journal|May 26, 2017
Survival difference according to mutation status in a prospective cohort study of Australian patients with metastatic non-small-cell lung carcinomaLavinia Tan, Marliese Alexander, Ann Officer, et al.
Oral Oncology|September 5, 2020
Validation of local p16 testing for determination of human papilloma virus status eligibility on a low risk oropharyngeal cancer trial - A Trans-Tasman Radiation Oncology Group studyRichard J Young, Benjamin Solomon, June Corry, et al.
Molecular Cancer Research : MCR|October 20, 2011
Inhibition of DNA-dependent protein kinase induces accelerated senescence in irradiated human cancer cellsArun Azad, Susan Jackson, Carleen Cullinane, et al.
British Journal of Cancer|July 21, 2017
Lung cancer prognostic index: a risk score to predict overall survival after the diagnosis of non-small-cell lung cancerMarliese Alexander, Rory Wolfe, David Ball, et al.
Plos One|November 25, 2015
Spleen Volume Variation in Patients with Locally Advanced Non-Small Cell Lung Cancer Receiving Platinum-Based Chemo-RadiotherapyShu Wen Wen, Sarah J Everitt, Justin Bedő, et al.
ANZ Journal of Surgery|September 15, 2016
Impact of sex on prognostic host factors in surgical patients with lung cancerZoe Wainer, Gavin M Wright, Karla Gough, et al.
Asia-Pacific Journal of Clinical Oncology|March 1, 2014
Multicenter randomized, open-label phase II trial of sequential erlotinib and gemcitabine compared with gemcitabine monotherapy as first-line therapy in elderly or ECOG PS two patients with advanced NSCLCMichael Michael, Shane C White, Ehtesham Abdi, et al.
Medical Oncology (Northwood, London, England)|September 8, 2017
EGFR and KRAS mutations do not enrich for the activation of IL-6, JAK1 or phosphorylated STAT3 in resected lung adenocarcinomaTimothy D Clay, Prudence A Russell, Hongdo Do, et al.
Pageof 19